Author: Dr Val Phua
Estimated reading time: 12–14 minutes
What Is Corneal Cross-Linking?
Corneal cross-linking, commonly abbreviated as CXL, is a procedure used to strengthen a cornea that is becoming progressively thin, steep or structurally unstable.
It is most commonly performed for:
- Progressive keratoconus
- Corneal ectasia after LASIK or another refractive procedure
- Selected other progressive corneal ectatic conditions
The procedure combines riboflavin eye drops—a form of vitamin B2—with carefully controlled ultraviolet-A light. This produces a photochemical reaction within the corneal tissue, creating additional molecular bonds within its collagen framework.
These bonds increase the biomechanical stability of the cornea and reduce the likelihood of further steepening and distortion. Corneal cross-linking is currently the principal treatment for stopping or slowing progressive keratoconus.
What Cross-Linking Is Designed to Do
The primary purpose of cross-linking is to stabilise the cornea.
It may:
- Stop or slow further corneal steepening
- Reduce progressive thinning
- Preserve existing visual potential
- Reduce the likelihood of increasingly irregular astigmatism
- Reduce the future need for corneal transplantation
- Stabilise selected cases of post-LASIK ectasia
Cross-linking may produce modest flattening or visual improvement in some patients, but these are secondary benefits rather than the main objective. Long-term studies have demonstrated sustained corneal stability for many patients for ten years or longer after treatment.
What Cross-Linking Does Not Do
Cross-linking does not reliably:
- Restore a completely normal corneal shape
- Eliminate existing irregular astigmatism
- Remove established corneal scarring
- Guarantee clearer unaided vision
- Make every patient independent of glasses or contact lenses
- Replace rigid or scleral lenses when these remain necessary
- Cure keratoconus permanently
- Prevent progression in every treated eye
A successful result may simply mean that the cornea remains stable instead of continuing to deteriorate.
This may not feel dramatic in the short term, but preventing progression during adolescence or early adulthood can preserve useful vision for decades.
Why Does Keratoconus Progress?
The cornea is made largely of organised collagen fibres and surrounding extracellular tissue.
In keratoconus, the cornea becomes mechanically weaker. A localised area may progressively:
- Become thinner
- Bulge forwards
- Become steeper
- Develop irregular astigmatism
- Scatter light rather than focusing it clearly
As the shape becomes increasingly irregular, spectacles may provide less satisfactory vision. Patients may develop ghost images, glare, halos and poor night vision.
Cross-linking does not remove the cone. It strengthens the remaining corneal tissue so that further deformation becomes less likely.
How Does Riboflavin and Ultraviolet Light Strengthen the Cornea?
Riboflavin acts as a photosensitiser.
When exposed to a controlled dose of ultraviolet-A light, it generates reactive oxygen species. These initiate chemical reactions that increase bonding within and between collagen fibres and other components of the corneal tissue.
Riboflavin also helps absorb ultraviolet light, reducing the amount that reaches deeper structures when the correct protocol and corneal-thickness requirements are followed.
Cross-linking is therefore not simply “shining ultraviolet light into the eye”. It is a carefully controlled combination of:
- Riboflavin concentration
- Corneal saturation
- Ultraviolet wavelength
- Ultraviolet intensity
- Total treatment energy
- Oxygen availability
- Corneal thickness
- Treatment duration
Different combinations form different cross-linking protocols.
Who Should Consider Corneal Cross-Linking?
Cross-linking is most commonly recommended when there is convincing evidence that keratoconus or corneal ectasia is progressing.
Possible evidence includes:
- Increasing maximum corneal curvature
- Increasing anterior or posterior elevation
- Progressive corneal thinning
- Worsening asymmetry
- Increasing myopia or astigmatism
- A changing astigmatic axis
- Reduced best-corrected vision
- Increasing higher-order aberrations
- Consistent deterioration across repeat corneal scans
The decision should not be based on one measurement alone. Scan quality, contact-lens warpage, dry eye and natural testing variability can create apparent changes that are not true progression. Current guidance supports combining tomography, refraction, visual function, age and the overall clinical pattern.
Does Everyone with Keratoconus Need Cross-Linking?
No.
A patient with mild but stable keratoconus may be monitored without immediate treatment.
Observation may be reasonable when:
- Repeat corneal scans remain stable
- The prescription is not changing significantly
- Vision is stable
- The patient is older and considered at lower risk of progression
- The cornea is too thin or scarred for the proposed protocol
- The risks currently outweigh the expected benefit
Cross-linking is generally not performed merely because the word “keratoconus” appears on a scan.
The aim is to treat progressive or high-risk disease before irreversible structural damage develops.
Why Is Age Important?
Keratoconus often begins during adolescence and early adulthood.
Younger corneas generally have a greater lifetime opportunity to progress, and paediatric keratoconus may deteriorate more rapidly than adult disease. Children and teenagers may therefore require:
- More frequent tomography
- Earlier repeat measurements
- Aggressive control of allergy and eye rubbing
- A lower threshold for treatment when the diagnosis is convincing
Systematic reviews support both standard and accelerated cross-linking as effective stabilising treatments in appropriately selected paediatric patients.
Age alone does not determine treatment. Progression can still occur in adults, including patients over 30 or 40.
Should Cross-Linking Be Performed Before Progression Is Documented?
This decision is individualised.
In many adults, repeat scans are used to confirm progression before treatment.
In a young child or teenager with definite keratoconus, advanced asymmetry, significant eye rubbing and a high-risk corneal shape, waiting for clear deterioration may allow avoidable damage to occur.
The updated international consensus supports considering:
- Patient age
- Disease severity
- Likelihood of follow-up
- Family history
- Eye rubbing and allergy
- Corneal thickness
- Rate of change
- Vision in the other eye
before deciding whether documented progression is essential in every case.
What Happens Before Cross-Linking?
A detailed assessment is required to confirm that treatment is appropriate.
Refraction and Visual Acuity
The examination measures:
- Unaided vision
- Best spectacle-corrected vision
- Myopia and astigmatism
- Changes from previous prescriptions
A changing prescription may support progression, but it must be interpreted together with the corneal scans.
Corneal Topography and Tomography
Corneal imaging evaluates:
- Anterior corneal curvature
- Posterior corneal elevation
- Corneal thickness
- The thinnest point
- Thickness progression
- Cone location
- Overall ectatic pattern
Tomography is essential for confirming the diagnosis, documenting progression and planning a safe treatment protocol.
Corneal Thickness
Corneal thickness is important because ultraviolet treatment must not expose the corneal endothelium and deeper structures to unsafe energy levels.
The traditional epithelium-off Dresden protocol generally requires the corneal stroma to reach at least approximately 400 micrometres during treatment. Modified protocols may be considered for thinner corneas, but their evidence, treatment depth and safety differ.
Slit-Lamp Examination
The ophthalmologist checks for:
- Corneal scarring
- Active infection
- Significant inflammation
- Severe allergy
- Dry-eye disease
- Previous herpes infection
- Contact-lens-related damage
- Other ocular conditions
Active allergic or inflammatory eye disease should generally be controlled before treatment because postoperative rubbing, inflammation and epithelial-healing problems may increase risk.
Contact-Lens Discontinuation
Contact lenses can temporarily alter corneal shape.
Patients may need to stop wearing them before the final scans. The duration depends on:
- Soft versus rigid lenses
- Scleral lenses
- Wearing schedule
- Degree of corneal warpage
- Stability of repeated measurements
Rigid and scleral lenses usually require a longer period out of lenses than soft lenses.
The Main Types of Corneal Cross-Linking
The term “cross-linking” includes several different procedures.
The most important distinction is whether the corneal epithelium is removed.
Epithelium-Off Cross-Linking
Epithelium-off cross-linking, commonly called epi-off CXL, is the most established technique.
The epithelium is the thin surface layer of the cornea. During epi-off treatment, a central area of epithelium is removed to allow riboflavin, ultraviolet light and oxygen to reach the underlying corneal stroma effectively.
A typical procedure involves:
- Applying anaesthetic eye drops
- Removing the central epithelium
- Applying riboflavin repeatedly
- Confirming adequate corneal saturation and thickness
- Delivering controlled ultraviolet-A light
- Applying antibiotic drops
- Placing a bandage contact lens
Epi-off CXL has the strongest and longest-established evidence for stabilising progressive keratoconus and post-refractive-surgery ectasia.
Epithelium-On Cross-Linking
Epithelium-on cross-linking, or epi-on CXL, leaves the surface epithelium intact.
Potential advantages include:
- Less postoperative pain
- Faster surface recovery
- Lower risk of epithelial infection
- Reduced risk of delayed epithelial healing
- Earlier return to routine activities
The main challenge is that the intact epithelium limits the penetration of riboflavin, ultraviolet light and oxygen.
Older transepithelial protocols generally produced less reliable treatment effects than established epi-off protocols. Newer approaches use techniques such as:
- Specialised riboflavin formulations
- Iontophoresis
- Supplemental oxygen
- Pulsed ultraviolet delivery
- Different energy protocols
Recent reviews suggest that some modern epi-on protocols can stabilise keratoconus, but results are protocol-specific. Evidence from one proprietary system should not automatically be applied to every procedure marketed as “epi-on cross-linking”.
Epi-Off Versus Epi-On Cross-Linking
| Feature | Epi-off CXL | Epi-on CXL |
|---|---|---|
| Epithelium | Removed centrally | Left intact |
| Evidence base | Longest and most established | Improving but protocol-dependent |
| Riboflavin penetration | More predictable | More technically challenging |
| Early discomfort | Greater | Usually less |
| Epithelial healing | Required | Minimal surface disruption |
| Infection risk | Small but present until healing | Potentially lower |
| Treatment effect | Generally deeper and well established | May be shallower or variable with some protocols |
| Suitable patients | Most progressive keratoconus cases with adequate thickness | Selected patients using a validated system |
| Recovery | Slower during first week | Usually faster |
The best procedure is not simply the least uncomfortable one. It is the protocol most likely to provide adequate stabilisation for the individual cornea.
What Is Conventional Cross-Linking?
The original Dresden protocol uses:
- Epithelium removal
- Riboflavin saturation
- Ultraviolet-A light at 3 mW/cm²
- Approximately 30 minutes of irradiation
- A total energy dose of 5.4 J/cm²
This protocol has extensive clinical evidence and remains an important reference standard.
What Is Accelerated Cross-Linking?
Accelerated CXL uses higher ultraviolet intensity over a shorter period.
Examples include irradiation lasting several minutes rather than 30 minutes.
The aim is to deliver a similar total energy dose while reducing procedure time. However, corneal cross-linking is oxygen-dependent, and simply increasing intensity does not guarantee an identical biological effect.
Meta-analyses of randomised trials suggest that standard and accelerated epi-off protocols generally provide comparable safety and visual outcomes, although differences in corneal flattening and treatment depth may occur between specific protocols.
What Is Pulsed Cross-Linking?
Pulsed CXL alternates periods of ultraviolet exposure with brief pauses.
The pauses may allow oxygen to diffuse back into the corneal tissue and support the photochemical reaction.
Studies suggest that pulsed protocols can stabilise keratoconus, but the results depend on:
- Ultraviolet intensity
- On-and-off cycle
- Riboflavin formulation
- Epithelium status
- Oxygen delivery
- Total energy
Pulsed treatment should therefore be evaluated as a particular protocol rather than as a single uniform technique.
What Is Iontophoresis-Assisted Cross-Linking?
Iontophoresis uses a weak electrical current to encourage riboflavin to pass through an intact epithelium.
This may reduce treatment time and discomfort.
A 2026 systematic review found that both standard epi-off and iontophoresis-assisted protocols can stabilise keratoconus, but standard CXL generally produced greater corneal flattening.
Can Thin Corneas Be Cross-Linked?
Possibly, but not always using the conventional protocol.
When the cornea is thinner than the standard safety threshold, modified techniques may include:
- Hypo-osmolar riboflavin to swell the cornea
- Contact-lens-assisted CXL
- Individualised ultraviolet dosing
- Reduced treatment zones
- Transepithelial techniques
- Customised or sub-400 protocols
Systematic reviews suggest that modified CXL can stabilise selected corneas below 400 micrometres, but the available studies use different methods and follow-up periods. Safety and efficacy should therefore be considered separately for each protocol.
An extremely thin, severely scarred or advanced cornea may not be suitable for cross-linking and may require specialised contact lenses or corneal transplantation.
What Happens on the Day of Epi-Off Cross-Linking?
Before Treatment
The eye is checked to confirm:
- No active infection
- Adequate corneal thickness
- Correct treatment eye
- Stable clinical condition
Contact lenses should already have been discontinued according to the clinic’s instructions.
Anaesthetic Drops
Topical anaesthetic drops numb the surface.
The patient remains awake and usually sees lights and movement without feeling sharp pain during treatment.
Removing the Epithelium
A central circular area of surface epithelium is gently removed.
This allows riboflavin to penetrate the corneal stroma.
Riboflavin Soaking
Riboflavin drops are applied repeatedly for a specified period.
The surgeon may check:
- Corneal saturation
- Anterior-chamber riboflavin flare
- Corneal thickness
- Surface hydration
Ultraviolet-A Treatment
The patient looks towards a fixation light while ultraviolet-A energy is delivered.
Riboflavin drops may continue to be applied during irradiation according to the protocol.
The eyelids are held open gently, and the surgeon monitors centration, corneal hydration and patient comfort.
Bandage Contact Lens
A soft bandage lens is placed at the end of epi-off treatment to protect the exposed surface while the epithelium regrows.
Antibiotic and other prescribed drops are then started.
How Long Does Cross-Linking Take?
The total visit is longer than the ultraviolet exposure alone.
A conventional procedure may require:
- Preparation and anaesthesia
- Epithelial removal
- Approximately 30 minutes of riboflavin application
- Approximately 30 minutes of ultraviolet treatment
- Post-procedure examination
Accelerated protocols shorten the ultraviolet phase, although preparation and riboflavin saturation still require time.
Is Cross-Linking Painful?
The eye is numb during the procedure.
After epi-off CXL, patients commonly experience:
- Burning
- Stinging
- Watering
- Light sensitivity
- Foreign-body sensation
- Eyelid squeezing
- Blurred vision
Discomfort is usually greatest during the first one to three days while the epithelium heals.
Pain control may involve:
- Oral pain medication
- Cold compresses around the closed eyelids
- Prescribed lubricants
- Cycloplegic medication in selected patients
- The bandage contact lens
Do not apply unapproved anaesthetic drops at home. Repeated topical anaesthetic use can delay healing and cause severe corneal damage.
How Long Does the Surface Take to Heal?
The epithelium commonly heals over several days.
The bandage contact lens is generally removed after the surface has closed, often around the first postoperative review or according to the surgeon’s protocol.
Delayed healing may occur, particularly in patients with:
- Severe ocular allergy
- Dry eye
- Diabetes
- Ocular-surface disease
- Older age
- Poor postoperative hygiene
- Certain systemic conditions
Persistent pain, discharge or worsening redness requires urgent examination.
What Is the Recovery Timeline?
First Few Days
Common symptoms include:
- Pain or grittiness
- Watering
- Light sensitivity
- Blurred vision
- Hazy vision
- Difficulty keeping the eye open
Patients should rest, use their prescribed medication and avoid touching the eye.
First One to Two Weeks
After the epithelium heals:
- Pain usually improves substantially.
- Vision remains blurred or unstable.
- Light sensitivity gradually settles.
- The corneal surface continues to smooth.
- Some patients can return to desk work, depending on comfort and vision.
First One to Three Months
Vision and refraction may fluctuate.
The cornea may initially become temporarily steeper or hazier before stabilising. A new spectacle or contact-lens prescription should not be finalised prematurely.
Three to Twelve Months
Tomographic and refractive measurements gradually stabilise.
Some patients experience modest flattening and improved corrected vision. Others remain visually similar but show no further progression—which is still a successful outcome.
When Can I Return to Work?
This depends on:
- Epi-off versus epi-on treatment
- Which eye was treated
- Vision in the other eye
- Pain and light sensitivity
- Nature of the patient’s work
- Whether driving is required
Many patients undergoing epi-off CXL require several days away from work. Visually demanding, outdoor or dusty occupations may require a longer recovery period.
When Can I Drive?
Do not drive while:
- Vision is blurred
- The bandage contact lens remains uncomfortable
- Light sensitivity is significant
- Pain medication causes drowsiness
- The treated eye interferes with depth perception
- You do not meet the legal driving standard
Your surgeon should advise when driving is safe.
When Can Contact Lenses Be Worn Again?
Do not reinsert ordinary contact lenses while the corneal surface is healing.
Rigid, hybrid and scleral lenses may need to be refitted after the corneal shape has begun stabilising. The timing varies but may be several weeks or longer.
An old lens may no longer fit safely because cross-linking can alter corneal curvature.
Resume lens wear only after the cornea has been examined and the lens fit has been approved.
What Should I Avoid After Cross-Linking?
Follow the surgeon’s specific instructions.
Common precautions include:
- Do not rub the eye.
- Do not remove or manipulate the bandage lens.
- Avoid swimming and hot tubs.
- Avoid eye makeup until permitted.
- Avoid dusty, smoky or contaminated environments.
- Keep tap water, shampoo and soap away from the eye.
- Avoid contact sports during early healing.
- Use prescribed medication exactly as directed.
- Wear sunglasses for comfort outdoors.
- Attend every scheduled review.
What Eye Drops Are Used?
Postoperative medication may include:
- Antibiotic drops while the surface heals
- Preservative-free artificial tears
- Steroid drops after epithelial closure
- Cycloplegic medication in selected cases
- Other medication based on the individual eye
Steroid treatment must be monitored because it can raise eye pressure, delay healing or worsen certain infections.
Do not continue, stop or alter prescribed drops without medical advice.
Can Both Eyes Be Treated on the Same Day?
Some centres perform simultaneous bilateral CXL, while others treat the eyes separately.
Potential advantages of same-day treatment include:
- One period of leave
- One recovery phase
- Earlier stabilisation of both eyes
Potential disadvantages include:
- Both eyes being uncomfortable simultaneously
- Greater temporary functional visual difficulty
- A rare infection or healing problem potentially affecting both eyes
- Difficulty relying on the untreated eye during recovery
The decision depends on:
- Disease severity in each eye
- Visual function
- Patient age
- Ability to manage bilateral recovery
- Surgeon and clinic protocol
- Whether both eyes genuinely require treatment
What Are the Common Side Effects?
Expected temporary effects include:
- Pain
- Blurred vision
- Light sensitivity
- Corneal haze
- Surface staining
- Dryness
- Fluctuating vision
- Temporary reduction in visual acuity
- Temporary corneal steepening or flattening
Clinical trials and treatment guidance identify corneal haze, epithelial defects, punctate keratitis, pain, photophobia and blurred vision among the common early effects of epi-off treatment.
What Are the Possible Complications?
Less common complications include:
- Delayed epithelial healing
- Bacterial or fungal corneal infection
- Sterile corneal infiltrates
- Significant corneal scarring
- Persistent haze
- Reactivation of herpes-simplex keratitis
- Corneal melting in a severely compromised surface
- Endothelial-cell damage
- Persistent visual reduction
- Raised eye pressure from steroid treatment
- Continued ectatic progression
The risk is higher when the cornea is extremely thin, the ocular surface is unhealthy, allergy is uncontrolled or postoperative instructions are not followed.
What Symptoms Require Urgent Review?
Contact the treating clinic promptly for:
- Increasing pain after initial improvement
- Worsening redness
- Thick or sticky discharge
- Sudden reduction in vision
- A white spot on the cornea
- Increasing eyelid swelling
- Marked light sensitivity
- Loss or displacement of the bandage lens accompanied by pain
- Symptoms that are much worse than expected
A painful red eye after cross-linking should not be treated as ordinary postoperative discomfort without examination.
How Effective Is Cross-Linking?
Epi-off cross-linking stabilises most appropriately selected eyes with progressive keratoconus.
The American Academy of Ophthalmology’s evidence review concluded that epi-off CXL reduces progression in most treated keratoconus and post-refractive-ectasia eyes with an acceptable safety profile.
Long-term studies have reported continued stability and maintained visual improvements for many patients at ten years. However, no treatment has a 100% success rate.
Can Keratoconus Still Progress After Cross-Linking?
Yes.
Progression after treatment may reflect:
- A very steep or advanced cornea
- Young age and aggressive disease
- Continued vigorous eye rubbing
- Poorly controlled allergy
- Inadequate treatment effect
- A shallower protocol
- Initial measurement variability
- Natural biological differences
A large 2025 study estimated failure rates of approximately 2% at three years and 4.5% at five years when failure was defined by further treatment or transplantation, although the risk varies according to the population, severity and protocol used.
Cross-linking therefore reduces risk rather than eliminating it.
How Is Progression Assessed After Treatment?
Follow-up may include:
- Visual acuity
- Refraction
- Slit-lamp examination
- Corneal topography
- Corneal tomography
- Pachymetry
- Epithelial mapping
- Comparison with preoperative scans
Early postoperative measurements can fluctuate and should not automatically be labelled treatment failure.
True progression should be based on a consistent pattern over time using reliable, comparable measurements.
Can Cross-Linking Be Repeated?
Yes, in selected cases.
Repeat cross-linking may be considered when:
- Genuine progression is confirmed
- The cornea remains sufficiently thick
- The first treatment effect was inadequate
- Other causes of measurement change have been excluded
- The expected benefit outweighs the additional risk
Recent studies and reviews suggest that repeat CXL can stabilise many eyes that progress after an initial procedure. However, the evidence base is smaller than for primary treatment, and the decision must be individualised.
Will Cross-Linking Improve My Glasses Prescription?
Possibly, but not predictably.
Some eyes become slightly flatter or more regular, producing:
- Reduced corneal steepness
- Lower astigmatism
- Better corrected vision
- Improved contact-lens tolerance
Other eyes show little refractive change.
Patients should not undergo cross-linking with the expectation that it will eliminate glasses.
Will I Still Need Rigid or Scleral Contact Lenses?
Many patients do.
Cross-linking stabilises the corneal structure but does not necessarily eliminate existing irregularity.
After recovery, vision may still be improved with:
- Spectacles in mild disease
- Rigid gas-permeable lenses
- Hybrid lenses
- Scleral lenses
- Customised soft lenses
Lens fitting may become more predictable once the cornea is stable.
Can Cross-Linking Be Combined with Other Procedures?
Yes, but combined treatment requires careful planning.
Possible procedures include:
- Intracorneal ring segments
- Topography-guided PRK
- Phototherapeutic keratectomy
- Implantable Collamer Lens surgery after stability
- Cataract surgery in older patients
Each procedure addresses a different problem.
Cross-Linking
Aims to stabilise the cornea.
Ring Segments or Topography-Guided Treatment
May improve corneal shape or optical regularity.
ICL or Cataract Surgery
May correct part of the remaining refractive error.
Combined treatment does not suit every patient. Removing corneal tissue in keratoconus requires particularly cautious planning because the cornea is already biomechanically vulnerable. Evidence suggests that combining customised PRK with CXL may improve refractive outcomes in selected patients, but it should not be interpreted as routine laser vision correction for keratoconus.
Can Cross-Linking Be Performed After LASIK?
Yes, when progressive post-LASIK ectasia is confirmed.
The aim is to reduce further corneal steepening and instability. Cross-linking does not replace tissue removed during LASIK and may be less predictable in post-refractive ectasia than in primary keratoconus.
Additional visual correction may require:
- Glasses
- Rigid or scleral lenses
- Selected intracorneal ring segments
- Carefully planned refractive treatment after stability
- Corneal transplantation in advanced cases
Can Cross-Linking Prevent the Need for a Corneal Transplant?
It may substantially reduce the likelihood by stabilising keratoconus before advanced thinning and scarring occur.
However, transplantation may still be required when:
- Significant central scarring is already present
- The cornea is extremely thin or steep
- Contact lenses no longer provide functional vision
- Cross-linking is unsuitable
- Disease progresses despite treatment
- Acute hydrops causes severe scarring
Early detection and timely stabilisation provide the best opportunity to preserve the patient’s own cornea.
Can Cross-Linking Be Performed During Pregnancy?
Elective cross-linking is generally deferred during pregnancy.
Hormonal changes may alter the cornea, and safety data for the procedure during pregnancy are limited. The US prescribing information for one established riboflavin-UVA system advises that it should not be performed during pregnancy.
Patients who are pregnant, planning pregnancy or breastfeeding should discuss:
- Current disease severity
- Evidence of progression
- Timing of treatment
- Monitoring frequency
- Individual risks and benefits
Rapid visual or tomographic change during pregnancy should still be assessed promptly.
Can Cross-Linking Be Performed After Corneal Hydrops?
Not during active acute hydrops.
Hydrops causes sudden corneal swelling after a break in the deepest corneal layer. The cornea should first be allowed to heal and stabilise.
After recovery, treatment options depend on:
- Residual thickness
- Degree of scarring
- Visual potential
- Contact-lens tolerance
- Continued evidence of progression
Some eyes may no longer be suitable for conventional cross-linking and may require corneal transplantation.
Frequently Asked Questions
Is corneal cross-linking surgery?
It is generally classified as a minimally invasive corneal procedure.
No large incision is made, but epi-off treatment removes the surface epithelium and requires sterile technique, postoperative medication and close follow-up.
Is cross-linking a laser procedure?
No.
It uses ultraviolet-A light rather than an excimer laser. It does not reshape the cornea by removing tissue in the way LASIK or PRK does.
Is riboflavin injected into the eye?
No.
Riboflavin is applied as eye drops to the corneal surface. It is not injected into the eyeball.
Is ultraviolet light dangerous to the eye?
Ultraviolet exposure can be harmful when uncontrolled.
During CXL, the wavelength, energy, duration, riboflavin concentration and corneal thickness are carefully controlled to limit exposure to deeper structures.
Can cross-linking make keratoconus worse?
The cornea may appear temporarily steeper or vision may worsen during early recovery. True sustained progression is uncommon but can occur if the treatment effect is inadequate.
Will my cornea become thicker after cross-linking?
Not necessarily.
The cornea may temporarily become thinner during early recovery and later return closer to baseline. Stabilisation does not require permanent thickening.
What is the “demarcation line”?
A line may become visible within the corneal stroma on examination or anterior-segment OCT after treatment.
It represents a transition between treated anterior tissue and deeper untreated tissue. Its depth may provide information about the treatment effect, but the presence or absence of a visible line does not independently prove long-term success.
Is conventional or accelerated CXL better?
Both can be effective.
Conventional CXL has the longest evidence base. Accelerated protocols reduce treatment time and generally provide comparable stabilisation when appropriately selected, but the effect depends on the particular energy and oxygen protocol.
Is epi-on always safer?
It usually causes less early surface discomfort and avoids an epithelial wound.
However, safety must be balanced against treatment effectiveness. Not all epi-on protocols produce the same riboflavin penetration or biomechanical effect.
Can children undergo cross-linking?
Yes.
Cross-linking is widely used in children with progressive or high-risk keratoconus. Paediatric treatment should be planned by a clinician experienced in corneal ectasia because progression and follow-up requirements differ from those in adults.
Should I stop rubbing my eyes after treatment?
Yes.
Cross-linking strengthens the cornea but does not make it indestructible. Continued forceful rubbing may place unnecessary stress on the cornea and worsen allergy or surface inflammation.
How soon can I obtain new glasses?
A temporary prescription may be given if needed, but a definitive prescription is usually delayed until refraction becomes sufficiently stable.
Can I wear my old rigid lens after treatment?
Not without review.
The corneal shape may have changed, and an old lens can fit poorly or damage the healing surface.
Can the treatment be repeated?
Yes, if genuine progression occurs and the cornea remains suitable. Repeat treatment should follow a careful review of the original protocol and postoperative scans.
Warning Signs Requiring Urgent Review
Seek prompt examination after cross-linking for:
- Increasing rather than improving pain
- Worsening redness
- Sudden reduction in vision
- A white or grey corneal spot
- Thick discharge
- Increasing light sensitivity
- Significant eyelid swelling
- Persistent epithelial defect
- New trauma to the eye
These may indicate infection, inflammation or delayed healing rather than routine recovery.
The Bottom Line
Corneal cross-linking strengthens a cornea that is becoming progressively unstable.
It combines:
- Riboflavin eye drops
- Controlled ultraviolet-A light
- A carefully selected treatment protocol
The primary objective is to stop or slow progression, not to provide spectacle-free vision.
Epi-off cross-linking has the longest and most established evidence base. Modern epi-on and accelerated techniques may offer advantages in selected patients, but their effectiveness depends on the exact riboflavin, ultraviolet, oxygen and energy protocol used.
Cross-linking works best when keratoconus is detected and treated before severe thinning or scarring develops.
Patients may still need:
- Glasses
- Rigid contact lenses
- Hybrid lenses
- Scleral lenses
- Additional treatment to improve optical quality
Follow-up remains necessary because a small proportion of corneas may continue progressing and require repeat treatment.
Glasses and contact lenses improve how you see. Cross-linking protects the cornea from becoming progressively worse.
References
- Jhanji V, et al. Corneal Ectasia Preferred Practice Pattern. Ophthalmology. 2024.
- Cortina MS, et al. Safety and Efficacy of Epithelium-Off Corneal Collagen Cross-Linking: An American Academy of Ophthalmology Report. Ophthalmology. 2024.
- Gomes JAP, et al. Global Consensus on Keratoconus and Ectatic Diseases—Updated Consensus. 2026.
- Yeh CY, et al. Accelerated Versus Conventional Corneal Collagen Cross-Linking for Keratoconus: A Meta-analysis of Randomised Controlled Trials. European Journal of Ophthalmology. 2025.
- Mohammadpour M, et al. Epithelium-On Versus Epithelium-Off Corneal Collagen Cross-Linking: Systematic Review and Meta-analysis. 2025.
- Mohammadi F, et al. Effectiveness and Safety of Cross-Linking in Keratoconus With Thin Corneas. 2025.
- Morgado CR, et al. Corneal Cross-Linking in Paediatric Populations: Systematic Review. 2025.
- Bordais J, et al. Conventional Epithelium-Off Corneal Cross-Linking in Progressive Keratoconus: Ten-Year Outcomes. 2024.
- Maskill D, et al. Repeat Corneal Collagen Cross-Linking After Failure of Primary Cross-Linking. British Journal of Ophthalmology. 2024.
- US Food and Drug Administration. Riboflavin Ophthalmic Solution and UVA Corneal Cross-Linking Prescribing Information. 2025.
